Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Pete who wrote (572)	9/14/1999 12:34:00 PM
From: Carter Berezay	Read Replies (1) \| Respond to of 792

Pete, if you re-look at the Globe's Saturday short listings you'll see that the 100,000 short share took place between August 15 and August 31, 1999. From the charts I would surmise the investor that dumped approximately 348,000 on the market approximately August 18/99 was dumping a 248,000 share block and then shorted another 100,000 shares on top of that. Thought they could make money from the short side. I recall the BIG trade changed hands at $2.15/share. I have no idea who crossed that BIG trade. Nesbitt was the biggest buyer yesterday and on other days it has been Yorkton on the buy side. There has been a bottom feeder for at least 3 weeks. They started with a 10,000 share bid at $2.53/share. It was always there. I suspect it was a fund company trying to scoop a position. Now they're having to pay up! As I said I don't know for nothing who the shorter is (or was). Everyone has their own ideas as to where MBI is headed. Since the BIG trade MBI shares have gone up about a $1.00 (46%). To the doubters I say "Checkmate!" Carter B.

To: Pete who wrote (572)	9/14/1999 12:39:00 PM
From: Graham Dellaire	Read Replies (1) \| Respond to of 792

According to the latest information the float is ~54 million shares... 100,000 shares short is really insignificant overall, but can affect a daily price if all the shares were re-bought (i.e. MBI goes up dramatically) in one day. The big affect comes from the small volume of shares usually traded each day (avg of 23,000 or something see below). FYI... TD has a more moderate price goal of 4.50 over the next 12 months (From May 14th which is before the recent fast-track announcement). That is probably closer to reality unless a big pharma partnership is announced to market and distribute MBI 226 within that time period. Cheers all and happy investing... Graham P.S. did anyone remember me recommending Affymetrix last year? It was 16 a share, now it is 112!!! US$